Oral contraceptive use and risk of vulvodynia: a population‐based longitudinal study
暂无分享,去创建一个
Laurie J. Legocki | M. Helmuth | H. Haefner | B. Gillespie | S. Harlow | B. Reed | LJ Legocki | ME Helmuth | H. Häfner | A. Sen | Siobán D. Harlow | Barbara D. Reed | Brenda W. Gillespie
[1] Ananda Sen,et al. Prevalence and demographic characteristics of vulvodynia in a population-based sample. , 2012, American journal of obstetrics and gynecology.
[2] C. Battaglia,et al. Sexual behavior and oral contraception: a pilot study. , 2012, The journal of sexual medicine.
[3] S. Caruso,et al. Conventional vs. extended-cycle oral contraceptives on the quality of sexual life: comparison between two regimens containing 3 mg drospirenone and 20 µg ethinyl estradiol. , 2011, The journal of sexual medicine.
[4] D. Erickson,et al. Self-reported vulvar pain characteristics and their association with clinically confirmed vestibulodynia. , 2009, Journal of women's health.
[5] B. Reed,et al. Vulvodynia in Preadolescent Girls , 2008, Journal of lower genital tract disease.
[6] G. Bachmann,et al. Assessment of vulvodynia symptoms in a sample of U.S. women: a follow-up national incidence survey. , 2008, Journal of women's health.
[7] Ananda Sen,et al. Vulvodynia Incidence and Remission Rates Among Adult Women: A 2-Year Follow-up Study , 2008, Obstetrics and gynecology.
[8] A. Vitonis,et al. Influence of oral contraceptive use on the risk of adult-onset vulvodynia. , 2008, The Journal of reproductive medicine.
[9] Ananda Sen,et al. Effect of test order on sensitivity in vulvodynia. , 2007, Journal of reproductive medicine.
[10] Ananda Sen,et al. Reliability and Validity of Self-Reported Symptoms for Predicting Vulvodynia , 2006, Obstetrics and gynecology.
[11] N. Avis,et al. Chronic vulvar and other gynecologic pain: prevalence and characteristics in a self-reported survey. , 2006, The Journal of reproductive medicine.
[12] S. Caruso,et al. Sexual behavior of women taking low-dose oral contraceptive containing 15 μg ethinylestradiol/60 μg gestodene , 2004 .
[13] S. Caruso,et al. Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene. , 2004, Contraception.
[14] H. Stenlund,et al. Prevalence and incidence of prolonged and severe dyspareunia in women: results from a population study , 2003, Scandinavian journal of public health.
[15] B. Harlow,et al. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? , 2003, Journal of the American Medical Women's Association.
[16] E. Rylander,et al. Vulvar pain, sexual behavior and genital infections in a young population: a pilot study , 2002, Acta obstetricia et gynecologica Scandinavica.
[17] J. Brisson,et al. Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. , 2002, American journal of epidemiology.
[18] D. Hellberg,et al. Vaginal microbiological flora, and behavioural and clinical findings in women with vulvar pain , 2001, BJOG : an international journal of obstetrics and gynaecology.
[19] E. Barrett-Connor,et al. Estrogen, apolipoprotein E, and dementia. , 1997, Journal of women's health.
[20] I. Sjöberg,et al. Vulvar vestibulitis in the north of Sweden. An epidemiologic case-control study. , 1997, The Journal of reproductive medicine.
[21] J. Woodruff,et al. Case-Control Study of Vulvar Vestibulitis Syndrome , 1995 .
[22] J. Brisson,et al. Vulvar Vestibulitis Syndrome: An Exploratory Case-Control Study , 1994, Obstetrics and gynecology.